DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
Alpha Vantage · ACCESS Newswire · · AI-summarised by FinFlash
DataMEDS AI announced an amended and restated non-binding letter of intent (LOI) to license and acquire intellectual property from several entities, including Datavault AI, Data Health Partners, EOS Technology Holdings, Scilex Holding Company, and HealthBridge Advisors. This transaction aims to consolidate IP enabling goal-driven prescription drug telehealth, medical drones, and healthcare blockchain technologies.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.